Billet examines the role of TGF-ß signaling in stromal fibroblasts on the expansion of melanoma, prostate, and renal cancer growth through novel mouse models.
Biondi studies the mechanisms of chromatin remodeling in prostate cancer and the development of novel xenograft model systems.
Choudhury is developing a biomarker system for determining if patients are likely to have indolent or aggressive prostate cancer, based on the role of folate metabolism detected in blood or urine.
Dru examines mechanisms of reducing bladder inflammation and paracrine factors that mediate stromal evolution of prostate cancer.
Fernandez develops and characterizes novel transgenic mouse models, in order to better understand prostate cancer progression.
Haldar examines the mechanistic role of stromal cytokines found to be predictive of prostate cancer metastatic progression.
Liu, a PhD student from Sichuan University, is currently working on the role of mesenchymal stem cells on the progression of prostate and head and neck cancer.
Mishra is determining the role of TGF-β and androgen signaling on epigenetic gene regulation in prostate cancer.
Tripathi is determining mechanisms that potentiate the expansion of stem features in prostate cancer epithelia at both the primary and bone metastatic site.